Holen Sie sich die Stockscreener-App
1.335
1.11%
-0.015
Schlusskurs vom Vortag:
$1.35
Offen:
$1.33
24-Stunden-Volumen:
23,087
Relative Volume:
0.11
Marktkapitalisierung:
$78.07M
Einnahmen:
$2.91M
Nettoeinkommen (Verlust:
$-220.40M
KGV:
-0.3668
EPS:
-3.64
Netto-Cashflow:
$-176.15M
1W Leistung:
+2.69%
1M Leistung:
+18.14%
6M Leistung:
-91.57%
1J Leistung:
-86.74%
1-Tages-Spanne:
$1.31
$1.40
1-Wochen-Bereich:
$1.26
$1.40
52-Wochen-Spanne:
$0.92
$22.50
Igm Biosciences Inc Stock (IGMS) Company Profile
Firmenname
Igm Biosciences Inc
Sektor
Branche
Telefon
650-965-7873
Adresse
325 E MIDDLEFIELD ROAD, MOUNTAIN VIEW
Vergleichen Sie IGMS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
IGMS
Igm Biosciences Inc
|
1.3364 | 78.07M | 2.91M | -220.40M | -176.15M | -3.64 |
|
VRTX
Vertex Pharmaceuticals Inc
|
502.76 | 127.64B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
606.37 | 65.95B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ARGX
Argen X Se Adr
|
655.71 | 37.92B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
269.39 | 32.98B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
254.24 | 26.89B | 3.81B | -644.79M | -669.77M | -6.24 |
Igm Biosciences Inc Stock (IGMS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-01-10 | Herabstufung | BMO Capital Markets | Outperform → Market Perform |
| 2025-01-10 | Herabstufung | Guggenheim | Buy → Neutral |
| 2025-01-10 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2025-01-10 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2025-01-10 | Herabstufung | Stifel | Buy → Hold |
| 2024-12-06 | Eingeleitet | BMO Capital Markets | Outperform |
| 2024-10-01 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2024-10-01 | Herabstufung | Truist | Buy → Hold |
| 2024-02-09 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2023-12-15 | Herabstufung | BofA Securities | Buy → Neutral |
| 2023-12-07 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2022-11-09 | Fortgesetzt | Jefferies | Buy |
| 2022-10-17 | Eingeleitet | JP Morgan | Neutral |
| 2022-08-29 | Eingeleitet | BofA Securities | Buy |
| 2021-12-13 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2021-11-05 | Hochstufung | Wedbush | Neutral → Outperform |
| 2021-08-26 | Eingeleitet | Morgan Stanley | Overweight |
| 2021-01-29 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2021-01-19 | Bestätigt | H.C. Wainwright | Buy |
| 2020-12-22 | Herabstufung | Wedbush | Outperform → Neutral |
| 2020-07-17 | Eingeleitet | Robert W. Baird | Outperform |
| 2020-07-01 | Eingeleitet | H.C. Wainwright | Buy |
| 2020-05-28 | Eingeleitet | SunTrust | Buy |
| 2020-04-22 | Eingeleitet | Wedbush | Outperform |
| 2019-10-14 | Eingeleitet | Guggenheim | Buy |
| 2019-10-14 | Eingeleitet | Jefferies | Buy |
| 2019-10-14 | Eingeleitet | Piper Jaffray | Overweight |
| 2019-10-14 | Eingeleitet | Stifel | Buy |
Alle ansehen
Igm Biosciences Inc Aktie (IGMS) Neueste Nachrichten
Renaissance Technologies LLC Raises Stock Holdings in IGM Biosciences, Inc. (NASDAQ:IGMS) - Defense World
IGM Biosciences, Inc. (NASDAQ:IGMS) Position Reduced by Price T Rowe Associates Inc. MD - MarketBeat
IGM Biosciences (NASDAQ:IGMS) Stock Price Down 1.5%Here's Why - MarketBeat
IGM Biosciences, Inc. (NASDAQ:IGMS) Shares Bought by Geode Capital Management LLC - Defense World
Press Release Distribution & PR Platform - ACCESS Newswire
Igm biosciences principal accounting officer sells $1,907 in stock - MSN
Fierce Biotech Layoff Tracker 2025: Mural lays off 90%; Tempest cuts 80% of roles - Fierce Biotech
IGMS stock touches 52-week low at $1 amid sharp annual decline - Investing.com
IGMS stock touches 52-week low at $1 amid sharp annual decline By Investing.com - Investing.com South Africa
IGM Bio stock slips as Bank of America downgrades (IGMS:NASDAQ) - Seeking Alpha
Short Interest in IGM Biosciences, Inc. (NASDAQ:IGMS) Decreases By 19.3% - MarketBeat
IGMS STOCK ALERT: Levi & Korsinsky Notifies IGM Biosciences, Inc. Investors of an Ongoing Investigation - ACCESS Newswire
IGMS stock plunges to 52-week low at $1.14 amid market challenges - Investing.com Australia
IGMS stock plunges to 52-week low at $1.14 amid market challenges By Investing.com - Investing.com South Africa
Charles Schwab Investment Management Inc. Buys 9,441 Shares of IGM Biosciences, Inc. (NASDAQ:IGMS) - Defense World
IGM Biosciences (NASDAQ:IGMS) Shares Up 5.9%What's Next? - MarketBeat
IGM Biosciences stock plunges to 52-week low of $1.59 - MSN
IGM Biosciences, Inc. (NASDAQ:IGMS) Given Average Rating of "Reduce" by Brokerages - MarketBeat
IGM Biosciences, Inc. (NASDAQ:IGMS) Receives $5.50 Consensus PT from Brokerages - Defense World
IGM Biosciences (NASDAQ:IGMS) Shares Up 5.9% – Here’s Why - Defense World
Sanofi Advances Immunology Ambitions With Dren Deal - insights.citeline.com
IGM Biosciences CEO Mary Beth Harler sells $9,014 in stock By Investing.com - Investing.com Australia
IGM Biosciences CFO Tahir Misbah sells shares worth $9,014 By Investing.com - Investing.com South Africa
IGM Biosciences chief business officer sells $5,549 in stock By Investing.com - Investing.com South Africa
IGM Biosciences CEO Mary Beth Harler sells $9,014 in stock - Investing.com India
IGM Biosciences chief business officer sells $5,549 in stock - Investing.com India
IGM Biosciences CFO Tahir Misbah sells shares worth $9,014 - Investing.com India
Igm biosciences officer sells shares worth $2,092 - Investing.com India
Igm biosciences officer sells shares worth $2,092 By Investing.com - Investing.com Australia
IGM Biosciences stock plunges to 52-week low at $1.17 By Investing.com - Investing.com Australia
IGM Biosciences stock plunges to 52-week low at $1.17 - Investing.com India
IGM Biosciences Faces Uncertainty Amid Cash Preservation and Restructuring Efforts - TipRanks
IGM Biosciences Inc reports results for the quarter ended December 31Earnings Summary - TradingView
IGM Biosciences Inc. (IGMS) reports earnings - qz.com
Contrasting IGM Biosciences (NASDAQ:IGMS) and Gyre Therapeutics (NASDAQ:GYRE) - Defense World
IGM Biosciences stock plunges to 52-week low of $1.25 By Investing.com - Investing.com Australia
IGM Biosciences stock plunges to 52-week low of $1.25 - Investing.com India
IGM Biosciences Inc expected to post a loss of 74 cents a shareEarnings Preview - TradingView
Finanzdaten der Igm Biosciences Inc-Aktie (IGMS)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.08%
0.47%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):